Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Sprycel
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Sprycel 100mg tablets
0801050ANBBADAD
|
Sprycel | Dasatinib | Malignant Disease and Immunosuppression | No data available |
|
Sprycel 10mg/ml oral suspension
0801050ANBBAGAG
|
Sprycel | Dasatinib | Malignant Disease and Immunosuppression | No data available |
|
Sprycel 140mg tablets
0801050ANBBAEAE
|
Sprycel | Dasatinib | Malignant Disease and Immunosuppression | No data available |
|
Sprycel 20mg tablets
0801050ANBBAAAA
|
Sprycel | Dasatinib | Malignant Disease and Immunosuppression | No data available |
|
Sprycel 50mg tablets
0801050ANBBABAB
|
Sprycel | Dasatinib | Malignant Disease and Immunosuppression | No data available |
|
Sprycel 70mg tablets
0801050ANBBACAC
|
Sprycel | Dasatinib | Malignant Disease and Immunosuppression | No data available |
|
Sprycel 80mg tablets
0801050ANBBAFAF
|
Sprycel | Dasatinib | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.